Atlas Trials

Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.

Clinical trial NCT02895061 · COMPLETED

Trial details

NCT number
NCT02895061
Sponsor
Phramongkutklao College of Medicine and Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis
Start date
2015-01-01
Primary completion
2015-10-01
Enrollment
502

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.